New Epstein Barr Virus Vaccine Coming

Nov. 30, 2011 - PRLog -- The Center for the Biology of Chronic Disease (CBCD) learned recently that “An Epstein-Barr virus (EBV) vaccine in the early phases of development may prove able to prevent infectious mononucleosis and EBV-associated cancers, without necessarily preventing the EBV infection itself.”

An article written by Lara C. Pullen, PhD and published in Medscape Medical News entitled “Epstein-Barr Virus Vaccine May Soon Enter Phase 3 Trial” stated that the new vaccine targets the EBV glycoprotein gp350, which is the most abundant glycoprotein on the virus and on virus-infected cells.


The Centers for Disease Control and Prevention(CDC) state that, “the Epstein-Barr virus, frequently referred to as EBV, is a member of the herpesvirus family and one of the most common human viruses. The virus occurs worldwide, and most people become infected with EBV sometime during their lives. In the United States, as many as 95% of adults between 35 and 40 years of age have been infected. Infants become susceptible to EBV as soon as maternal antibody protection (present at birth) disappears.

Many children become infected with EBV, and these infections usually cause no symptoms or are indistinguishable from the other mild, brief illnesses of childhood. In the United States and in other developed countries, many persons are not infected with EBV in their childhood years. When infection with EBV occurs during adolescence or young adulthood, it causes infectious mononucleosis 35% to 50% of the time.”

There is currently no cure for an Epstein Barr virus infection.

That is why the CBCD believes that Gene-Eden-VIR, developed by Biotechnology Company, polyDNA is such an important product! This all natural, EBV remedy boosts the immune system against the latent Epstein Barr virus through a scientifically designed, patented formula.

One recent user of Gene-Eden-VIR said this: “I work in construction and I can’t afford to be sick. When you work from paycheck to pay check you just can’t. Well, you know, I was having colds worse than normal. It had to have been some kind of virus. I would be extremely tired, dragging myself out of bed with no energy at all, my head and body aching like I was getting beaten with a sledgehammer. Sometimes I literally couldn’t leave the bedroom or even the house. I can tell you I was really worried about getting behind on rent! Then I found out about Gene-Eden-VIR. I made myself go to work even though I felt like a truck was sitting on me, and I started taking Gene-Eden every day for about six weeks. I slowly started feeling better. I wasn’t sick as much, and I finally felt like I had the energy to work a full day without feeling like I was going to an early grave. Gene-Eden-VIR really works! It’s about time a company came out with something natural that’s not just a bunch of hype!” - Javier G. -  El Paso, TX

Most people may wonder whether Gene-Eden-VIR is affordable, safe and effective.

In order to cut costs and pass savings on to Gene-Eden-VIR’s users, it is marketed and sold exclusively online through the Gene-Eden website and is only $34.99 per bottle (about a month’s supply.)

Gene-Eden-VIR is extremely safe. In over three years of being in the marketplace, there have been no reported side effects. Moreover, each Gene-Eden-VIR capsule contains a patented formula of five all natural ingredients including selenium, camellia sinesis extract, quercetin, cinnamomum extract, and licorice extract. In addition, each bottle is GMP Certified.

(If a product is GMP Certified it means that the product is keeping good manufacturing practices as outlined by the Food and Drug Administration [FDA].)

Gene-Eden-VIR is highly effective against latent viruses; each ingredient was selected through a scientific approach. PolyDNA scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world in order to identify the safest, most effective natural ingredients that target the latent (chronic) Epstein Barr (EBV) virus. Moreover, polyDNA developed Gene-Eden-VIR without the use of animal testing.

You can easily access these scientific papers on the ingredients of Gene-Eden-VIR on pubmed.gov, and you can find a select few on the Gene-Eden website at Gene-Eden.com.

“Gene-Eden combines several proven substances that work harmoniously to help boost the body’s own immune system or have other antiviral properties. The scientific data with regard to the immune enhancing and antiviral properties published in reputable sources on each individual compound in the Gene-Eden formula is impressive. Use of this product clearly has scientific merit based on published material.” – Dr. Norman Cohen, M.D.

To learn more about Gene-Eden-VIR, the only product on the market today that helps the body maintain low concentrations of the latent Epstein Barr virus (HPV) and that is scientifically backed by published material, or to learn more about how Gene-Eden-VIR was developed without the use of animal testing, or to schedule an interview with a polyDNA scientist, please visit http://www.Gene-Eden.com .

# # #

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.